Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2021;32(4):363-6
Article Links
Cardiovascular Magnetic Resonance Detects Myocardial Inflammation in Giant Cell Arteritis
Sophie I. Mavrogeni1,2, Athanasios Koutroumpas3
Authors Information

1. Onassis Cardiac Surgery Center, Athens, Greece

2. National and Kapodistrian University of Athens, Athens, Greece

3. Private practice, Volos, Greece

Keywords: GCA, CMR, tocilizumab, corticosteroids, sacubitril/valsartan
References
  1. Mavrogeni SI, Dimitroulas T, Kitas GD. Cardiovascular magnetic resonance in the diagnosis and management of cardiac and vascular involvement in the systemic vasculitides. Curr Opin Rheumatol 2019;31(1):16-24.  
  2. Simon R, Perel-Winkler A, Bokhari S, Fazlollahi L, Nickerson K. Myocarditis in Giant Cell Arteritis Diagnosed With Fluorine 18-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography: Case Report and Review of the Literature. J Clin Rheumatol 2020;26(2):e37-e40.
  3. Mohamed R, Djama D, Ayoub T. Diagnostic positron emission tomography-computedtomography in clinically elusive giant cell arteritis. Indian J Ophthalmol 2018;66(5):693-4.
  4. Sammel AM, Hsiao E, Schrieber L, Janssen B, Youssef P, Fraser CL, et al. Fluorine-18 Fluoro-2- Deoxyglucose Positron Emission Tomography Uptake in the Superficial Temporal and Vertebral Arteries in Biopsy Positive Giant Cell Arteritis. J Clin Rheumatol 2017;23(8):443.
  5. Zhang R, Shen J, Jiang W, Wei X, Qin L, Ding E. Giant Cell Arteritis Incidentally Detected by Positron Emission Tomography-Computed Tomography in a Patient With Atypical Symptoms. J Clin Rheumatol 2017;23(2):115-16.
  6. Nielsen BD, Gormsen LC. 18F-Fluorodeoxyglucose PET/Computed Tomography in the Diagnosis and Monitoring of Giant Cell Arteritis. PET Clin 2020;15(2):135-45.
  7. Salvarani C, Soriano A, Muratore F, Shoenfeld Y, Blockmans D. Is PET/CT essential in the diagnosis and follow-up of temporal arteritis? Autoimmun Rev 2017;16(11):1125-30.
  8. Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol 2018;72(24):3158-76.
  9. Bechman K, Gopalan D, Nihoyannopoulos P, Mason JC. A cohort study reveals myocarditis to be a rare and life-threatening presentation of large vessel vasculitis. Semin Arthritis Rheum 2017;47(2):241-6.
  10. Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. JAMA 2016;315(22):2442-58.
  11. Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, et al. Trial of Tocilizumab in Giant-Cell Arteritis. N Engl J Med 2017;377(4):317-28.
  12. Kobayashi H, Kobayashi Y, Giles JT, Yoneyama K, Nakajima Y, Takei M. Tocilizumab treatment increases left ventricular ejection fraction and decreases left ventricular mass index in patients with rheumatoid arthritis without cardiac symptoms: assessed using 3.0 tesla cardiac magnetic resonance imaging. J Rheumatol 2014;41(10):1916-21.
  13. Khder Y, Shi V, McMurray JJV, Lefkowitz MP. Sacubitril/Valsartan (LCZ696) in Heart Failure. Handb Exp Pharmacol 2017;243:133-65.